Home

JOHN R MOORE

CIK 1191702 · General Counsel · last filed 2026-08-17

JOHN R MOORE is a General Counsel who has filed 59 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for EWTX, was dated Aug 17, 2026. Across all open-market trades the lifetime net is −$4.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $932.4K across reported positions. 36 SEC filings were submitted jointly with ARRAY BIOPHARMA INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$932.4K

Companies

2

Total Filings

59

Lifetime Open-Market Net

-$4.45M

Filer Profile

Reported Address
3200 WALNUT ST
BOULDER, CO 80301
Related Filers
ARRAY BIOPHARMA INC — 36 joint filings, latest 2017-04-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EWTX General Counsel 22,713 $41.05 $932.4K -$4.45M 25 2026-08-17
ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted Director — — — $0 2 2016-09-14

Recent Filings

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-17 EWTX Grant (A) — $0 EDGAR
2026-08-14 EWTX Mixed +7,483 -$219.8K EDGAR
2025-08-14 EWTX Mixed +3,683 -$28.1K EDGAR
2025-05-07 EWTX Mixed +3,279 -$31.8K EDGAR
2024-09-24 EWTX Mixed — -$1.95M EDGAR
2024-09-23 EWTX Notice (144) −20,922 -$578.1K EDGAR
2024-09-20 EWTX Notice (144) −50,000 -$1.42M EDGAR
2024-08-14 EWTX Grant (A) — $0 EDGAR
2024-05-03 EWTX Mixed +3,252 -$37.0K EDGAR
2024-02-09 EWTX Mixed — -$539.2K EDGAR
Showing 1–10 of 59
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.